DMAP: A connectivity map database to enable identification of novel drug repositioning candidates

BMC Bioinformatics

Volumn 16, Issue 13, 2015, Pages

  Huang, Hui ^a   Nguyen, Thanh ^a   Ibrahim, Sara ^a   Shantharam, Sandeep ^a   Yue, Zongliang ^a   Chen, Jake Y ^a,b  

^a INDIANA UNIVERSITY   (United States)

^b WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DATABASE SYSTEMS; GENE EXPRESSION; MAPS;

COMPUTATIONAL TECHNIQUE; CONFIDENCE MEASURE; DRUG REPOSITIONING; GENE EXPRESSION PROFILES; KOLMOGOROV-SMIRNOV; RELIABLE MEASUREMENT; SIMILARITY-BASED METHODS; TRADITIONAL TECHNIQUES;

PROTEINS;

PROTEIN;

CHEMISTRY; DRUG REPOSITIONING; FACTUAL DATABASE; PROCEDURES; UTILIZATION;

DATABASES, FACTUAL; DRUG REPOSITIONING; PROTEINS;

EID: 84961640984     PISSN: None     EISSN: 14712105     Source Type: Journal    
DOI: 10.1186/1471-2105-16-S13-S4     Document Type: Article

References (33)

1. Gottlieb A, et al: PREDICT: a method for inferring novel drug indications with application to personalized medicine. Mol Syst Biol. 2011, 7: 496-
2. Sirota M, et al: Discovery and preclinical validation of drug indications using compendia of public gene expression data. Sci Transl Med. 2011, 3 (96): 96ra77.-
3. Iorio F, et al: Discovery of drug mode of action and drug repositioning from transcriptional responses. Proc Natl Acad Sci USA. 2010, 107 (33): 14621-6.
4. DiMasi JA, RW Hansen, HG Grabowski: The price of innovation: new estimates of drug development costs. J Health Econ. 2003, 22 (2): 151-85.
5. Ashburn TT, KB Thor: Drug repositioning: identifying and developing new uses for existing drugs. Nat Rev Drug Discov. 2004, 3 (8): 673-83.
6. Keiser MJ, et al: Predicting new molecular targets for known drugs. Nature. 2009, 462 (7270): 175-81.
7. Campillos M, et al: Drug target identification using side-effect similarity. Science. 2008, 321 (5886): 263-6.
8. Li J, X Zhu, JY Chen: Building disease-specific drug-protein connectivity maps from molecular interaction networks and PubMed abstracts. PLoS Comput Biol. 2009, 5 (7): e1000450.-
9. Hu G, P Agarwal: Human disease-drug network based on genomic expression profiles. PLoS One. 2009, 4 (8): e6536.-
10. Lamb J: The Connectivity Map: a new tool for biomedical research. Nat Rev Cancer. 2007, 7 (1): 54-60.
11. Lamb J, et al: The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science. 2006, 313 (5795): 1929-35.
12. Dickson M, JP Gagnon: The cost of new drug discovery and development. Discov Med. 2004, 4 (22): 172-9.
13. Huang R, et al: The NCGC pharmaceutical collection: a comprehensive resource of clinically approved drugs enabling repurposing and chemical genomics. Sci Transl Med. 2011, 3 (80): 80ps16.
14. Kuhn M, et al: STITCH 3: zooming in on protein-chemical interactions. Nucleic Acids Res. 2012, 40 (Database): D876-80.
15. Davis AP, et al: The Comparative Toxicogenomics Database's 10th year anniversary: update 2015. Nucleic Acids Res. 2015, 43 (Database): D914-20.
16. Chen JY, S Mamidipalli, T Huan: HAPPI: an online database of comprehensive human annotated and predicted protein interactions. BMC Genomics. 2009, 10 (Suppl 1): S16.-
17. Chen JY, C Shen, AY Sivachenko: Mining Alzheimer disease relevant proteins from integrated protein interactome data. Pac Symp Biocomput. 2006, 367-78.
18. Zhu F, et al: Update of TTD: Therapeutic Target Database. Nucleic Acids Res. 2010, 38 (Database): D787-91.
19. Pacini C, et al: DvD: An R/Cytoscape pipeline for drug repurposing using public repositories of gene expression data. Bioinformatics. 2013, 29 (1): 132-4.
20. Barrett T, et al: NCBI GEO: archive for functional genomics data sets--update. Nucleic Acids Res. 2013, 41 (D1): D991-5.
21. Irizarry RA, et al: Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res. 2003, 31 (4): e15.-
22. Warnat P, R Eils, B Brors: Cross-platform analysis of cancer microarray data improves gene expression based classification of phenotypes. BMC Bioinformatics. 2005, 6: 265-
23. Chiang AP, AJ Butte: Systematic evaluation of drug-disease relationships to identify leads for novel drug uses. Clin Pharmacol Ther. 2009, 86 (5): 507-10.
24. Zhu F, et al: Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery. Nucleic Acids Res. 2012, 40 (Database): D1128-36.
25. Huang da W, et al: DAVID Bioinformatics Resources: expanded annotation database and novel algorithms to better extract biology from large gene lists. Nucleic Acids Res. 2007, 35 (Web Server): W169-75.
26. Walter SD: The partial area under the summary ROC curve. Stat Med. 2005, 24 (13): 2025-40.
27. Hoyert Donna, Xu Jiaquan: Deaths: Preliminary Data for 2011. National Vital Statistics Reports. 2012, 61 (6): October 10
28. Indolfi P, et al: Synchronous bilateral Wilms tumor: A report from the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP). Cancer. 2013
29. Do JS, et al: Therapeutic target validation of protein kinase C(PKC)-zeta for asthma using a mouse model. Int J Mol Med. 2009, 23 (4): 561-6.
30. Cheng D, et al: The effects of protein kinase C (PKC) on the tension of normal and passively sensitized human airway smooth muscle and the activity of voltage-dependent delayed rectifier potassium channel (Kv). J Huazhong Univ Sci Technolog Med Sci. 2007, 27 (2): 153-6.
31. Barnes PJ, NM Wilson, MJ Brown: A calcium antagonist, nifedipine, modifies exercise-induced asthma. Thorax. 1981, 36 (10): 726-30.
32. Groshong SD, et al: Biphasic regulation of breast cancer cell growth by progesterone: role of the cyclin-dependent kinase inhibitors, p21 and p27(Kip1). Mol Endocrinol. 1997, 11 (11): 1593-607.
33. Huang H, J Li, JY Chen: Disease gene-fishing in molecular interaction networks: a case study in colorectal cancer. Conference proceedings :... Annual International Conference of the IEEE Engineering in Medicine and Biology Society IEEE Engineering in Medicine and Biology Society Conference. 2009, 2009: 6416-9.